Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda. (2020)
Attributed to:
Pathogen Genomics, Phenotype and Immunity (PGPI) & Basic Sciences Programme
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/16549716.2020.1829829
PubMed Identifier: 33073737
Publication URI: http://europepmc.org/abstract/MED/33073737
Type: Journal Article/Review
Volume: 13
Parent Publication: Global health action
Issue: 1
ISSN: 1654-9880